ライフサイエンスコーパス: reagin

1 was discovered and found to be able to carry reagin activity.

2 by nonreactive serologic tests (rapid plasma reagin and fluorescent treponemal antibody-absorbed), th

3 n developed for the serological detection of reagin antibodies in syphilis.

4 mend the use of the traditional rapid plasma reagin-based screening algorithm.

5 st for gonorrhea and chlamydia, rapid plasma reagin for syphilis) conducted at baseline, week 26, and

6 T. vaginalis and syphilis with rapid plasma reagin >/=1:8.

7 % (7.7-11.5) having high-titre (rapid plasma reagin >=1:8) infection, including 16.9% (11.9-24.0%) of

8 stitute for the MHA-TP and that the Spirotek Reagin II test could substitute for the RPR test as a sc

9 The Reagin II test was more apt to be reactive if the trepon

10 asma Reagin (RPR) card test and the SpiroTek Reagin II test.

11 here was 89.2% agreement between the RPR and Reagin II tests.

12 reactive test results than with rapid plasma reagin in 2 studies, one with a low-prevalence US popula

13 compared using predicate manual rapid plasma reagin (RPR) and fluorescent treponemal antibody absorpt

14 All donors with a positive rapid plasma reagin (RPR) and matched donors with negative RPR who we

15 results were further tested by rapid plasma reagin (RPR) and Treponema pallidum particle agglutinati

16 s, all samples were tested by a rapid plasma reagin (RPR) assay and a treponemal IgM Western blot ass

17 y of 80.7% versus 80.3% for the rapid plasma reagin (RPR) card test (Becton Dickinson Microbiology Sy

18 ed two nontreponemal tests, the rapid plasma Reagin (RPR) card test and the SpiroTek Reagin II test.

19 No new rapid plasmin reagin (RPR) seroreactivity in young children is require

20 e cohort of patients with known rapid plasma reagin (RPR) statuses and clinical diagnoses of syphilis

21 e obtained using a quantitative rapid plasma reagin (RPR) test and the Treponema pallidum passive par

22 ed for all episodes of positive rapid plasma reagin (RPR) test results and on a subset with higher RP

23 s serological testing using the rapid plasma reagin (RPR) test with that of the combination of serolo

24 ogists unblinded to results of rapid plasmid reagin (RPR) testing of the same specimens.

25 n biologic false-positive (BFP) rapid plasma reagin (RPR) tests among persons infected with human imm

26 Automated nontreponemal rapid plasma reagin (RPR) tests were recently introduced in the Unite

27 nsmission can be assessed using rapid plasma reagin (RPR) tests, reflecting current or recent infecti

28 In multivariate analyses, serum rapid plasma reagin (RPR) titer > or =1 : 32 increased the odds of ne

29 We compared the rapid plasma reagin (RPR) titer on the day of initial presentation wi

30 reactors, that is, persons with rapid plasma reagin (RPR) titers > or = 1:4 and negative results for

31 Rapid plasma reagin (RPR) titers were determined every 3-6 months for

32 ) may have a slower decrease in rapid plasma reagin (RPR) titers.

33 test results: immunoassays and rapid plasma reagin (RPR), respectively, with RPR quantification by e

34 s underwent reflex testing with rapid plasma reagin (RPR), Treponema pallidum particle agglutination

35 hilis that were not detected by rapid plasma reagin (RPR).

36 munoassay [EIA] reactive and reactive plasma reagin [RPR] nonreactive) are resolved with a second tre

37 -treponemal serology (using the rapid plasma reagin [RPR] test).

38 treated for high-titer (n=133; rapid plasma reagin [RPR] titer > or = 1:8 and Treponema pallidum hem

39 by a nontreponemal test (i.e., rapid plasma reagin [RPR]) to assess disease activity and treatment s

40 ather than nontreponemal tests (rapid plasma reagin [RPR]).

41 for use in conjunction with the rapid plasma reagin test (RPR) as a method to test for syphilis.

42 ive (CIA(+)) specimens with the rapid plasma reagin test (RPR).

43 als, 360 (14.4%) had a positive rapid plasma reagin test at screening; 333 (92.5%) had a positive con

44 he search began for the factor, later called reagin, that could mediate an allergy, such as allergic

45 ve syphilis (i.e., women with a rapid plasma reagin titer > or = 1 :8 and a positive Treponema pallid

46 ive status or a decrease in the rapid plasma reagin titer by two or more dilutions at 6 months, refer

47 me 400 mg in achieving a 4-fold rapid plasma reagin titer decrease by 3 or 6 months after treatment.

48 n was higher in patients with a rapid plasma reagin titer of >/=1:8 (97.3%) than in those with a tite

49 ty was higher with higher serum rapid plasma reagin titers (P < .001), and in those treated for uncom

50 d bilirubin levels and elevated rapid plasma reagin titers.

51 ua New Guinea, with high-titre (rapid plasma reagin titre >/=1:8) latent or active yaws, between Apri

52 d as a two-dilution decrease in rapid plasma reagin titre by 24 months after treatment.

53 dum haemagglutination test and rapid plasmin reagin titre of >/=1:8) was higher in cases of yaws (63%

54 ultaneously evaluated using the rapid plasma reagin, Treponema pallidum particle agglutination, and c